BNTC · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2022-05-16 compared with 2022-02-14 · 0 added, 5 removed, 22 unchanged (19% of the section changed)
1 unchanged sentence
Description of Document
−Removed: Amended and Restated Certificate of Incorporation of Benitec Biopharma Inc.
−Removed: (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on April 15, 2020)
−Removed: Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Benitec Biopharma Inc., effective December 17, 2021 (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on December 21, 2021)
−Removed: First Amendment to Benitec Biopharma Inc.
−Removed: 2020 Equity and Incentive Compensation Plan, dated as of December 8, 2021 (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed on October 22, 2021)
Statement of CEO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
19 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.